ABEIXI™
标准物质
| CPSU011 | Sulphuric Acid 0.1M according to Chinese Pharmacopoeia (ChP) |
| CPSU20251 | Sulphuric Acid 0.25M according to Chinese Pharmacopoeia (ChP) |
| CPSU051 | Sulphuric Acid 0.5M according to Chinese Pharmacopoeia (ChP) |
| CPTBAH01F | Tetrabutylammonium Hydroxide 0.1M according to Chinese Pharmacopoeia (ChP) |
| CP60051 | Zinc Sulphate 0.05M according to Chinese Pharmacopoeia (ChP) |
| JAMP1 | 0.2M Sodium Phosphate (pH 6.8 ± 0.1 at 20°C) Mobile Phase Buffer according to Japanese Pharmacopoeia (JP) |
| JPAMSOLD1 | Ammonia Test Solution according to Japanese Pharmacopoeia |
| JPASSS01 | Arsenic Stock Solution according to Japanese Pharmacopoeia (JP) |
| JPCACL1 | Calcium Chloride 75 g/L in Water TS Solution according to Japanese Pharmacopoeia (JP) |
| JPED2011 | EDTA 0.1M according to Japanese Pharmacopoeia |
| JPH20201 | Hydrochloric Acid 0.2M according to Japanese Pharmacopoeia |
| JPHCLDIL1 | Hydrochloric Acid Dilute according to Japanese Pharmacopoeia |
| JPI2005F | Iodine 0.05M according to Japanese Pharmacopoeia |
| JPSPBSOL1 | Lead Stock Solution according to Japanese Pharmacopoeia |
| JPMGNETOH | Magnesium Nitrate in Ethanol (1 in10) Solution according to Japanese Pharmacopoeia (JP) |
| JPP2002F | Perchloric Acid 0.02M in Acetic Acid according Japanese Pharmacopoeia |
| JPP2010F | Perchloric Acid 0.1M according to Japanese Pharmacopoeia |
| KHXHSB201 | Potassium Hexahydroxoantimonate (V) 20 g/L in Water TS Solution according to Japanese Pharmacopoeia (JP) |
| JPPP2002F | Potassium Permanganate 0.02M according to Japanese Pharmacopoeia |
| JPN20100F | Silver Nitrate 0.1M according to Japanese Pharmacopoeia |
| JPS20101 | Sodium Hydroxide 0.1M according to Japanese Pharmacopoeia |
| JPS21001 | Sodium Hydroxide 1M according to Japanese Pharmacopoeia |
| JPT20101 | Sodium Thiosulfate 0.1M according to Japanese Pharmacopoeia |
| JPSU20051 | Sulfuric Acid 0.05M according to Japanese Pharmacopoeia |
| JPSU20501 | Sulfuric Acid 0.5M according to Japanese Pharmacopoeia |
| JPSULDIL1 | Sulphuric Acid Dilute according to Japanese Pharmacopoeia |
| DB18-121 | 1st Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DB18-10 | 1st Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DB15-121 | 2nd Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DB15-10L | 2nd Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DBC15-960 | 2nd Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) Concentrate |
| DBC15-250 | 2nd Dissolution Fluid Dissolution Media in accordance to Japanese Pharmacopoeia (JP) Concentrate |
| DB26-10 | Acetate Buffer 0.02M pH 5 Dissolution Media |
| DBC46-960 | Acetate Buffer pH 4.5 and 0.5% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC47-960 | Acetate Buffer pH 4.5 and 1.0% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB06-20 | Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB06-121 | Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC06-960 | Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC06-250 | Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC06-230 | Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB16-121 | Acetate Buffer pH 5.5 Dissolution Media in accordance to European Pharmacopoeia (EP) |
| DB17-121 | Acetate Buffer pH 5.8 Dissolution Media in accordance to European Pharmacopoeia (EP) |
| DB27-121 | Buffered Sodium Dodecyl Sulphate pH 7 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB27-10 | Buffered Sodium Dodecyl Sulphate pH 7 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB21-10 | Citrate Buffer 0.05M pH 6.00 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB28-10L | Di Sodium Phosphate 55.3g and Citric Acid 4.8g Adjust to pH 6.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| FASSIF5 | FaSSIF pH 6.5 without Enzyme Dissolution Media |
| FASSIFV210 | FaSSIF V2 pH 6.5 without Enzyme Dissolution Media |
| FASSIFV21 | FaSSIF V2 pH 6.5 without Enzyme Dissolution Media |
| FESSIF5 | FESSIF Phosphate Buffer pH 5 without Enzyme Dissolution Media |
| FESSIFV210 | FeSSIF V2 pH 5.8 without Eenzyme Dissolution Media |
| FESSIFV21 | FeSSIF V2 pH 5.8 without Enzyme Dissolution Media |
| DBC48-960 | Hydrochloric Acid 0.1N and 0.5% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB10-25L | Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB10-121 | Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC10-960 | Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC10-250 | Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC10-230 | Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC49-960 | Hydrochloric Acid 0.1N and 1.0% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB11-25L | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB11-20 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB11-121 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB11-10 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC11-960 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC11-250 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC11-230 | Hydrochloric Acid 0.1N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB19-10 | Hydrochloric Acid/Sodium Chloride pH 1.2 Dissolution Media in accordance to European Pharmacopoeia (EP) |
| DB20-10 | Phosphate Buffer pH 4.5 Dissolution Media in accordance to European Pharmacopoeia (EP) |
| DBC14-960 | Phosphate Buffer pH 6.8 Dissolution Media in accordance to Japanese Pharmacopoeia (JP) Concentrate |
| DBC14-500 | Phosphate Buffer pH 6.8 Dissolution Media in accordance to Japanese Pharmacopoeia (JP) Concentrate |
| DBC25-960 | Potassium Chloride 0.05M Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC25-400 | Potassium Chloride 0.05M Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB01-121 | Potassium Phosphate pH 5.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC01-960 | Potassium Phosphate pH 5.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC01-250 | Potassium Phosphate pH 5.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC01-230 | Potassium Phosphate pH 5.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC02-230 | Potassium Phosphate pH 6.0 Dissolution Media in accordance to United States (USP and European Pharmacopoeias (EP) Concentrate |
| DB02-121 | Potassium Phosphate pH 6.0 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC02-960 | Potassium Phosphate pH 6.0 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC02-250 | Potassium Phosphate pH 6.0 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC45-960 | Potassium Phosphate pH 6.8 and 0.5% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC44-960 | Potassium Phosphate pH 6.8 and 1.0% Sodium Dodecyl Sulphate Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC03-960 | Potassium Phosphate pH 6.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC03-250 | Potassium Phosphate pH 6.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC03-230 | Potassium Phosphate pH 6.8 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB03-121 | Potassium Phosphate pH 6.8 R Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB03-10 | Potassium Phosphate pH 6.8 R Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DB14-121 | Potassium Phosphate pH 6.80 Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DB14-10L | Potassium Phosphate pH 6.80 Dissolution Media in accordance to Japanese Pharmacopoeia (JP) |
| DB04-121 | Potassium Phosphate pH 7.2 Dissolution Media in accordance to Chinese (CP) United States (USP) and European Pharmacopoeias (EP) |
| DBC04-230 | Potassium Phosphate pH 7.2 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias ( EP) Concentrate |
| DB04-10L | Potassium Phosphate pH 7.2 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) |
| DBC04-960 | Potassium Phosphate pH 7.2 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC04-250 | Potassium Phosphate pH 7.2 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DB08-25L | Potassium Phosphate pH 7.4 Dissolution Media in accordance to Chinese (CP) United States (USP) and European Pharmacopoeias (EP) |
| DB08-121 | Potassium Phosphate pH 7.4 Dissolution Media in accordance to Chinese (CP) United States (USP) and European Pharmacopoeias (EP) |
| DB08-10L | Potassium Phosphate pH 7.4 Dissolution Media in accordance to Chinese (CP) United States (USP) and European Pharmacopoeias (EP) |
| DBC08-960 | Potassium Phosphate pH 7.4 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC08-250 | Potassium Phosphate pH 7.4 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |
| DBC08-230 | Potassium Phosphate pH 7.4 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate |